Philippe Menu, Chief Medical Officer at SOPHiA GENETICS, sold SOPH on Aug 12, 2026

Data as of Oct 16

▼ SELL$37.6K5,000 shares at $7.52Philippe Menu Chief Medical OfficerSOPH SOPHiA GENETICS SA

Watch SOPH

Traded: Aug 12, 2026
Disclosed: Aug 14, 2026
Filed: 2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

SOPHSimilar stocks (S&P 500 (SPY)), rebased to SOPH's price on the disclosure day

SOPH since disclosure

−10.3%

after the sale

Similar stocks (SPY) since disclosure

−1.7%

S&P 500 (SPY)

Change in closing price from Aug 14, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on SOPH →